The negative impact of anemia on radiotherapy and chemoradiation outcomes

Haffty, 1997, Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials, J Clin Oncol, 15, 268, 10.1200/JCO.1997.15.1.268 Hellman, 2001, Principles of cancer management: Radiation therapy, 265 Curt, 2000, Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition, Oncologist, 5, 353, 10.1634/theoncologist.5-5-353 Vogelzang, 1997, Patient, caregiver, and oncologist perceptions of cancer-related fatigue. Results of a tripart assessment survey. The Fatigue Coalition, 34, 4 Sabbatini, 2000, Contribution of anemia to fatigue in the cancer patient, Oncology, 14, 69 Becker, 2000, Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas, Int J Radiat Oncol Biol Phys, 46, 459, 10.1016/S0360-3016(99)00384-3 Brizel, 1999, Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome, Radiother Oncol, 53, 113, 10.1016/S0167-8140(99)00102-4 Höckel, 1993, Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix, Gynecol Oncol, 51, 141, 10.1006/gyno.1993.1262 Strauss, 1999, Prognostic impact of changes in the tumor tissue pO2 during early radiotherapy in cervical cancers: Improved local control in primarily hypoxic tumors with “reoxygenarion” and the impact of hemoglobin, Int J Radiat Oncol Biol Phys, 45, 364, 10.1016/S0360-3016(99)90437-6 Feldmann, 1999, Blood flow and oxygenation status of human tumors: Clinical investigations, Strahlenther Onkol, 175, 1, 10.1007/BF02743452 Teicher, 1995, Physiologic mechanisms of therapeutic resistance: Blood flow and hypoxia, Hematol Oncol Clin North Am, 9, 475, 10.1016/S0889-8588(18)30105-9 Warde, 1998, T1/T2 glottic cancer managed by external beam radiotherapy. The influence of pretreatment hemoglobin on local control, Int J Radiat Oncol Biol Phys, 41, 347, 10.1016/S0360-3016(98)00062-5 Evans, 1997, Evaluation of the concept of “hypoxic fraction” as a descriptot of tumor oxygenation status, Adv Exp Med Biol, 411, 215, 10.1007/978-1-4615-5865-1_26 Palcic, 1984, Reduced oxygen enhancement ratio at low doses of ionizing radiation, Radiat Res, 100, 328, 10.2307/3576354 Alarcón, 1999, Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation, Cancer Res, 59, 6046 Denko, 2001, Tumor hypoxia, the physiologic link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis, Cancer Res, 61, 795 Graeber, 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours, Nature, 379, 88, 10.1038/379088a0 Rockwell, 1997, Oxygen delivery: Implications for the biology and therapy of solid tumors, Oncol Res, 9, 383 Smaniotto, 2000, Prognostic significance of anemia and role of erythropoietin in radiation therapy, Tumori, 86, 17, 10.1177/030089160008600104 Movsas, 2000, Increasing levels of hypoxia in prosrate carcinoma correlate significantly with increasing clinical stage and patient age: An Eppendorf pO2 study, Cancer, 89, 2018, 10.1002/1097-0142(20001101)89:9<2018::AID-CNCR19>3.3.CO;2-P Höckel, 1993, Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix, Radiother Oncol, 26, 45, 10.1016/0167-8140(93)90025-4 Fyles, 1998, Oxygenation predicts radiation response and survival in parients with cervix cancer, Radiother Oncol, 48, 149, 10.1016/S0167-8140(98)00044-9 Harrison, 2000, Prevalence of anemia in cancer patients undergoing radiotherapy, 19, 471a Dische, 1991, Radiotherapy and anaemia—The clinical experience, Radiother Oncol, 20, 35, 10.1016/0167-8140(91)90184-I Bush, 1986, The significance of anemia in clinical radiarion therapy, Int J Radiat Oncol Biol Phys, 12, 2047, 10.1016/0360-3016(86)90146-X Dubray, 1996, Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study, Radiology, 201, 553, 10.1148/radiology.201.2.8888257 Fein, 1995, Pretreatment hemoglobin level influences local control and survival of T1–T2 squamous cell carcinomas of rhe glottic larynx, J Clin Oncol, 13, 2077, 10.1200/JCO.1995.13.8.2077 Lee, 1998, Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27, Int J Radiat Oncol Biol Phys, 42, 1069, 10.1016/S0360-3016(98)00348-4 Stadler, 1999, Influence of the hypoxic subvolume on rhe survival of patients with head and neck cancer, Inr J Radiat Oncol Biol Phys, 44, 749, 10.1016/S0360-3016(99)00115-7 Dunphy, 1989, The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate, Int J Radiat Oncol Biol Phys, 16, 1173, 10.1016/0360-3016(89)90277-0 Fazekas, 1989, The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15, Int J Radiat Oncol Biol Phys, 17, 1177, 10.1016/0360-3016(89)90523-3 Medical Research Council, 1987, Does initial hemoglobin level modify rhe efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer, Int J Radiat Oncol Biol Phys, 52, 965, 10.1080/09553008714552541 Girinski, 1989, Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients, Int J Radiat Oncol Biol Phys, 16, 37, 10.1016/0360-3016(89)90007-2 Overgaard, 1996, Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers, 6, 10 Bush, 1978, Definitive evidence for hypoxic cells influencing cure in cancer therapy, Br J Cancer, 37, 302 Goodnough, 1999, Transfusion medicine. Blood transfusion, N Engl J Med, 340, 438, 10.1056/NEJM199902113400606 Rieger, 1995, A new approach to managing chemotherapy-related anemia: Nursing implications of epoetin alfa, 22, 71 Walker, 1987, Special report: Transfusion risks, Am J Clin Pathol, 88, 374, 10.1093/ajcp/88.3.374 Busch, 1993, Blood transfusions and prognosis in colorectal cancer, N Engl J Med, 328, 1372, 10.1056/NEJM199305133281902 Heiss, 1994, Blood transfusion-modulated tumor recurrence. First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery, J Clin Oncol, 12, 1859, 10.1200/JCO.1994.12.9.1859 Houbiers, 1994, Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer, Lancet, 344, 573, 10.1016/S0140-6736(94)91965-8 Jensen, 1996, Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery, Lancet, 348, 841, 10.1016/S0140-6736(96)06168-5 Lavey, 1993, Erythropoietin increases hemoglobin in cancer patients during radiation therapy, Int J Radiat Oncol Biol Phys, 27, 1147, 10.1016/0360-3016(93)90536-5 Dusenbery, 1994, Erythropoietin increases hemoglobin during radiation therapy for cervical cancer, Int J Radiat Oncol Biol Phys, 29, 1079, 10.1016/0360-3016(94)90403-0 Sweeney, 1998, Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Final report of a randomized, open-labelled, phase II trial, Br J Cancer, 77, 1996, 10.1038/bjc.1998.331 Glaser, 1998, R-HuErythropoetin supply increases efficacy of neoadjuvant radiochemotherapy in patients with oral squamous cell carcinoma, 17, 397a Glaser, 1999, Impact of hemoglobin (Hgb) level and use of recombinant human erythropoietin (r-HuEPO) on response to neoadjuvant chemoradiation therapy, tumor control, and survival in patients with oral or oropharyngeal squamous cell carcinoma (SCCA), Int J Radiat Oncol Biol Phys, 45, 149, 10.1016/S0360-3016(99)90028-7